Glioblastoma Precision Medicine Program
The Glioblastoma Precision Medicine Program seeks to develop precision therapies for GBM through genomic profiling and individualized treatment regimens.
The UCSF Glioblastoma Precision Medicine Program assembles multi‑disciplinary projects that aim to advance treatment for glioblastoma through genomic data collection, individualized therapy trials, CAR‑T cell development, adeno‑associated viral gene therapy, and evolutionary mapping of tumors under therapy.
Glioblastoma is an aggressive brain tumor with poor survival outcomes; precision medicine approaches hold promise for improving therapeutic efficacy and patient quality of life.
Bizonyítékszint: Korai humán adat. Kis vagy feltáró emberi adat.
Kapcsolódó jelek
- Glioma
- Glioblastoma Clinical Trials for New Treatments
- Clinical trial links oncolytic immunoactivation to survival in glioblastoma
- Treating the invisible target: treatment planning targeting the microscopic tumor spread in gliomas
- EGFR inhibition down-regulates MGMT and enhances responsiveness to temozolomide in glioblastoma